Impact of visceral adiposity for coronary artery calcification progression in patients with metabolic dysfunction-associated fatty liver disease; multicenter cohort study

被引：0
|
作者：
Kang, Min Kyu [1 ]
Kim, KyeWhon [2 ]
Song, Jung Eun [3 ]
Park, Jung Gil [1 ]
机构：
[1] Yeungnam Univ, Coll Med, Internal Med, Gyongsan, South Korea
[2] Yeungnam Univ Hosp, Gyongsan, South Korea
[3] Daegu Catholic Univ, Sch Med, Gyongsan, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-558
引用
收藏
页码：S645 / S646
页数：2
相关论文
共 50 条
  • [41] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE INCREASES COLON CANCER RISK: A NATIONWIDE COHORT STUDY
    Lee, Hye Won
    Kim, Seung Up
    GUT, 2021, 70 : A10 - A11
  • [42] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    Hepatology International, 2023, 17 : 626 - 635
  • [43] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [44] A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
    Efrem, Ion Cristian
    Mota, Maria
    Vladu, Ionela Mihaela
    Mitrea, Adina
    Clenciu, Diana
    Timofticiuc, Diana Cristina Protasiewicz
    Diaconu, Ileana-Diana
    Turcu, Adina
    Crisan, Anda Elena
    Geormaneanu, Cristiana
    Glodeanu, Adina Dorina
    Mahler, Beatrice
    Tudor, Marinela Sinziana
    Amzolini, Anca Maria
    Micu, Simona Elena
    Abu Alhija, Anca Barau
    Mita, Adrian
    Filip, Maria Monalisa
    Fortofoiu, Maria
    DIAGNOSTICS, 2022, 12 (10)
  • [45] LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
    Leow, Yong Wen
    Chan, Wah Loong
    Lai, Lee Lee
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    Quiambao, Ronald
    Munteanu, Mona
    Chan, Wah Kheong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (10) : 2182 - 2189
  • [46] Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Onishi, Saori
    Fukuda, Akira
    Matsui, Masahiro
    Ushiro, Kosuke
    Nishikawa, Tomohiro
    Asai, Akira
    Kim, Soo Ki
    Nishikawa, Hiroki
    NUTRIENTS, 2023, 15 (18)
  • [47] LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Kim, Byung Ik
    Sohn, Won
    Kwon, Heon-Ju
    Cho, Yong Kyun
    HEPATOLOGY, 2021, 74 : 1022A - 1022A
  • [48] Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sohn, Won
    Kwon, Heon-Ju
    Chang, Yoosoo
    Ryu, Seungho
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1135 - E1148
  • [49] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
  • [50] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
12345